Skip to content

The effect of administering the different type of plasma substitute on the cord blood gas analysis during cesarean section

The effect of administering the different type of plasma substitute on the cord blood gas analysis during cesarean section - The effect of different plasma substitute on cord blood gas analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005694
Enrollment
100
Registered
2011-06-06
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing cesarean section under spinal anesthesia

Interventions

Administering 6% hydroxyethyl starch(HES) that contains a physiologically balanced medium as an initial infusion A total infusion volume of HES is 1500ml Administering 6% hydroxyethyl starch(HES) tha

Sponsors

Department of Anesthesiology and Medical Crisis Management, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients undergoing cesarean section who met the criteria of the American Society of Anesthesiologists physical status of 1-2

Exclusion criteria

Exclusion criteria: ASA physical status >=3, Obesity (BMI>35), Height>=175cm, Weight>=80Kg

Design outcomes

Primary

MeasureTime frame
To compare the cord blood gas analysis between administering 6% hydroxyethyl starch that contains a physiologically balanced medium or normal saline solution

Secondary

MeasureTime frame
To assess the time required from a hysterotomy start to delivery of fetus, hypotensive presence in the anesthesia, the use of the circulation agent, and other complications

Countries

Japan

Contacts

Public ContactYoshihito Fujita

Nagoya City University Graduate School of Medical Sciences Department of Anesthesiology and Medical Crisis Management

fujitayoshihito@yahoo.co.jp052-851-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026